![Andre J. Gudger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andre J. Gudger
Directeur/Bestuurslid bij
CytoDel LLC
Profiel
Andre J.
Gudger is currently the Director at CytoDel LLC.
Previously, he was the Chairman & Chief Executive Officer at Solvern Innovations, Inc. from 2003 to 2009.
He obtained an undergraduate degree from the University of Maryland and an MBA from The University of North Carolina at Charlotte.
Actieve functies van Andre J. Gudger
| Bedrijven | Functie | Begin |
|---|---|---|
CytoDel LLC
 CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Directeur/Bestuurslid | - |
Eerdere bekende functies van Andre J. Gudger
| Bedrijven | Functie | Einde |
|---|---|---|
Solvern Innovations, Inc.
 Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Voorzitter | 01-01-2009 |
Opleiding van Andre J. Gudger
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
9
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solvern Innovations, Inc.
Solvern Innovations, Inc. Information Technology ServicesTechnology Services Provides information technology development and consultation services | Technology Services |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoDel LLC
CytoDel LLC BiotechnologyHealth Technology Operates as a biopharmaceutical company which produces recombinant derivatives of botulinum neurotoxin | Health Technology |
